{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:02:30Z","timestamp":1777032150119,"version":"3.51.4"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100015659","name":"Cure Parkinson's Trust","doi-asserted-by":"publisher","award":["SC01"],"award-info":[{"award-number":["SC01"]}],"id":[{"id":"10.13039\/100015659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007394","name":"Instituto Nacional de Ci\u00eancia e Tecnologia de Ci\u00eancia Animal","doi-asserted-by":"publisher","award":["PTDC\/MED-NEU\/3644\/2020"],"award-info":[{"award-number":["PTDC\/MED-NEU\/3644\/2020"]}],"id":[{"id":"10.13039\/501100007394","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In Parkinson's patients, intestinal dysbiosis can occur years before clinical diagnosis, implicating the gut and its microbiota in the disease. Recent evidence suggests the gut microbiota may trigger body<jats:bold>-<\/jats:bold>first Parkinson Disease (PD), yet the underlying mechanisms remain unclear. This study aims to elucidate how a dysbiotic microbiome through intestinal immune alterations triggers PD<jats:bold>-<\/jats:bold>related neurodegeneration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To determine the impact of gut dysbiosis on the development and progression of PD pathology, wild-type male C57BL\/6 mice were transplanted with fecal material from PD patients and age<jats:bold>-<\/jats:bold>matched healthy donors to challenge the gut-immune-brain axis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This study demonstrates that patient-derived intestinal microbiota caused midbrain tyrosine hydroxylase positive (TH\u2009+) cell loss and motor dysfunction. Ileum-associated microbiota remodeling correlates with a decrease in Th17 homeostatic cells. This event led to an increase in gut inflammation and intestinal barrier disruption. In this regard, we found a decrease in CD4\u2009+\u2009cells and an increase in pro-inflammatory cytokines in the blood of PD transplanted mice that could contribute to an increase in the permeabilization of the blood\u2013brain-barrier, observed by an increase in mesencephalic Ig<jats:bold>-<\/jats:bold>G<jats:bold>-<\/jats:bold>positive microvascular leaks and by an increase of mesencephalic IL<jats:bold>-<\/jats:bold>17 levels, compatible with systemic inflammation. Furthermore, alpha-synuclein aggregates can spread caudo-rostrally, causing fragmentation of neuronal mitochondria. This mitochondrial damage subsequently activates innate immune responses in neurons and triggers microglial activation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We propose that the dysbiotic gut microbiome (dysbiome) in PD can disrupt a healthy microbiome and Th17 homeostatic immunity in the ileum mucosa, leading to a cascade effect that propagates to the brain, ultimately contributing to PD pathophysiology. Our landmark study has successfully identified new peripheral biomarkers that could be used to develop highly effective strategies to prevent the progression of PD into the brain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13024-024-00766-0","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T15:03:09Z","timestamp":1729782189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Gut-first Parkinson\u2019s disease is encoded by gut dysbiome"],"prefix":"10.1186","volume":"19","author":[{"given":"M\u00e1rio F.","family":"Munoz-Pinto","sequence":"first","affiliation":[]},{"given":"Emanuel","family":"Candeias","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Melo-Marques","sequence":"additional","affiliation":[]},{"given":"A. Raquel","family":"Esteves","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Maranha","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o D.","family":"Magalh\u00e3es","sequence":"additional","affiliation":[]},{"given":"Diogo Reis","family":"Carneiro","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Sant\u2019Anna","sequence":"additional","affiliation":[]},{"given":"A. Raquel","family":"Pereira-Santos","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio E","family":"Abreu","sequence":"additional","affiliation":[]},{"given":"Daniela","family":"Nunes-Costa","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Alarico","sequence":"additional","affiliation":[]},{"given":"Igor","family":"Tiago","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Morgadinho","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Lemos","sequence":"additional","affiliation":[]},{"given":"Pedro N.","family":"Figueiredo","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Janu\u00e1rio","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Empadinhas","sequence":"additional","affiliation":[]},{"given":"Sandra Morais","family":"Cardoso","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"766_CR1","doi-asserted-by":"publisher","unstructured":"Sana TG, Lugo KA, Monack DM. T6SS: The bacterial \u201cfight club\u201d in the host gut. PLoS Pathog. 2017;13:e1006325-. Available from: https:\/\/doi.org\/10.1371\/journal.ppat.1006325.","DOI":"10.1371\/journal.ppat.1006325"},{"key":"766_CR2","doi-asserted-by":"crossref","unstructured":"Lin C-H, Chen C-C, Chiang H-L, Liou J-M, Chang C-M, Lu T-P, et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J Neuroinflammation. 2019;16:129. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31248424.","DOI":"10.1186\/s12974-019-1528-y"},{"key":"766_CR3","doi-asserted-by":"publisher","unstructured":"Wallen ZD, Demirkan A, Twa G, Cohen G, Dean MN, Standaert DG, et al. Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms. Nat Commun. 2022;13:6958. Available from: https:\/\/doi.org\/10.1038\/s41467-022-34667-x.","DOI":"10.1038\/s41467-022-34667-x"},{"key":"766_CR4","doi-asserted-by":"crossref","unstructured":"Esteves AR, Munoz-Pinto MF, Nunes-Costa D, Candeias E, Silva DF, Magalh\u00e3es JD, et al. Footprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria. Gut. 2023;72:73. Available from: http:\/\/gut.bmj.com\/content\/72\/1\/73.abstract.","DOI":"10.1136\/gutjnl-2021-326023"},{"key":"766_CR5","doi-asserted-by":"publisher","unstructured":"Braak H, Sastre M, Bohl JRE, de Vos RAI, Del Tredici K. Parkinson\u2019s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol. 2007;113:421\u20139. Available from: https:\/\/doi.org\/10.1007\/s00401-007-0193-x.","DOI":"10.1007\/s00401-007-0193-x"},{"key":"766_CR6","doi-asserted-by":"publisher","unstructured":"Braak H, R\u00fcb U, Gai WP, Del Tredici K. Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm. 2003;110:517\u201336. Available from: https:\/\/doi.org\/10.1007\/s00702-002-0808-2.","DOI":"10.1007\/s00702-002-0808-2"},{"key":"766_CR7","doi-asserted-by":"publisher","unstructured":"Hawkes CH, Del Tredici K, Braak H. Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007;33:599\u2013614. Available from: https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00874.x.","DOI":"10.1111\/j.1365-2990.2007.00874.x"},{"key":"766_CR8","doi-asserted-by":"publisher","unstructured":"Horsager J, Andersen KB, Knudsen K, Skj\u00e6rb\u00e6k C, Fedorova TD, Okkels N, et al. Brain-first versus body-first Parkinson\u2019s disease: a multimodal\u00a0imaging case-control study. Brain. 2020;143:3077\u201388. Available from: https:\/\/doi.org\/10.1093\/brain\/awaa238.","DOI":"10.1093\/brain\/awaa238"},{"key":"766_CR9","doi-asserted-by":"publisher","unstructured":"Svensson E, Horv\u00e1th-Puh\u00f3 E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, et al. Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol. 2015;78:522\u20139. Available from: https:\/\/doi.org\/10.1002\/ana.24448.","DOI":"10.1002\/ana.24448"},{"key":"766_CR10","doi-asserted-by":"publisher","unstructured":"Kim S, Kwon S, Kam T, Dawson VL, Dawson TM, Ko HS, et al. Transneuronal Propagation of Pathologic \u03b1-Synuclein from the Gut to the Brain Models Parkinson\u2019s Disease. Neuron. 2019;1\u201315. Available from: https:\/\/doi.org\/10.1016\/j.neuron.2019.05.035.","DOI":"10.1016\/j.neuron.2019.05.035"},{"key":"766_CR11","doi-asserted-by":"publisher","unstructured":"Van Den Berge N, Ferreira N, Gram H, Mikkelsen TW, Alstrup AKO, Casadei N, et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol. 2019;138:535\u201350. Available from: https:\/\/doi.org\/10.1007\/s00401-019-02040-w.","DOI":"10.1007\/s00401-019-02040-w"},{"key":"766_CR12","doi-asserted-by":"crossref","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s Disease. Cell. 2016;167:1469\u20131480.e12. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27912057.","DOI":"10.1016\/j.cell.2016.11.018"},{"key":"766_CR13","doi-asserted-by":"crossref","unstructured":"Sampson TR, Challis C, Jain N, Moiseyenko A, Ladinsky MS, Shastri GG, et al. A gut bacterial amyloid promotes \u03b1-synuclein aggregation and motor impairment in mice. Elife. 2020;9:e53111. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32043464.","DOI":"10.7554\/eLife.53111"},{"key":"766_CR14","doi-asserted-by":"crossref","unstructured":"Choi JG, Kim N, Ju IG, Eo H, Lim S-M, Jang S-E, et al. Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice. Sci Rep. 2018;8:1275. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29352191.","DOI":"10.1038\/s41598-018-19646-x"},{"key":"766_CR15","doi-asserted-by":"publisher","unstructured":"Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, et al. Colonic bacterial composition in Parkinson\u2019s disease. Movement Disorders. 2015;30:1351\u201360. Available from: https:\/\/doi.org\/10.1002\/mds.26307.","DOI":"10.1002\/mds.26307"},{"key":"766_CR16","doi-asserted-by":"crossref","unstructured":"Unger MM, Spiegel J, Dillmann K-U, Grundmann D, Philippeit H, B\u00fcrmann J, et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord. 2016;32:66\u201372. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1353802016303236.","DOI":"10.1016\/j.parkreldis.2016.08.019"},{"key":"766_CR17","doi-asserted-by":"crossref","unstructured":"Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H, et al. Colonic inflammation in Parkinson\u2019s disease. Neurobiol Dis. 2013;50:42\u20138. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S096999611200321X.","DOI":"10.1016\/j.nbd.2012.09.007"},{"key":"766_CR18","doi-asserted-by":"crossref","unstructured":"Campos-Acu\u00f1a J, Elgueta D, Pacheco R. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson\u2019s Disease. Front Immunol. 2019;10:239. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30828335.","DOI":"10.3389\/fimmu.2019.00239"},{"key":"766_CR19","doi-asserted-by":"crossref","unstructured":"Peralta Ramos JM, Iribarren P, Bousset L, Melki R, Baekelandt V, der Perren A. Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic \u03b1-Synuclein Administration. Front Immunol. 2019;10:80. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00080.","DOI":"10.3389\/fimmu.2019.00080"},{"key":"766_CR20","first-page":"179","volume":"300","author":"AS Harms","year":"2018","unstructured":"Harms AS, Thome AD, Yan Z, Schonho AM, Williams GP, Li X, et al. Peripheral monocyte entry is required for alpha-Synuclein induced in fl ammation and Neurodegeneration in a model of Parkinson disease. 2018;300:179\u201387.","journal-title":"Peripheral monocyte entry is required for alpha-Synuclein induced in fl ammation and Neurodegeneration in a model of Parkinson disease"},{"key":"766_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.pnpbp.2017.07.023","volume":"79","author":"F Tahmasebinia","year":"2017","unstructured":"Tahmasebinia F, Pourgholaminejad A. The role of Th17 cells in auto-inflammatory neurological disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2017;79:408\u201316.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"766_CR22","doi-asserted-by":"crossref","unstructured":"Omenetti S, Bussi C, Metidji A, Iseppon A, Lee S, Tolaini M, et al. The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17 Cells. Immunity. 2019\/06\/19. 2019;51:77\u201389.e6. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31229354.","DOI":"10.1016\/j.immuni.2019.05.004"},{"key":"766_CR23","doi-asserted-by":"crossref","unstructured":"Sano T, Kageyama T, Fang V, Kedmi R, Martinez CS, Talbot J, et al. Redundant cytokine requirement for intestinal microbiota-induced Th17 cell differentiation in draining lymph nodes. Cell Rep. 2021;36:109608. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2211124721010469.","DOI":"10.1016\/j.celrep.2021.109608"},{"key":"766_CR24","doi-asserted-by":"crossref","unstructured":"Villumsen M, Aznar S, Pakkenberg B, Jess T, Brudek T. Inflammatory bowel disease increases the risk of Parkinson\u2019s disease: a Danish nationwide cohort study 1977\u20132014. Gut. 2019;68:18 LP \u2013 24. Available from: http:\/\/gut.bmj.com\/content\/68\/1\/18.abstract.","DOI":"10.1136\/gutjnl-2017-315666"},{"key":"766_CR25","doi-asserted-by":"publisher","unstructured":"Aho VTE, Houser MC, Pereira PAB, Chang J, Rudi K, Paulin L, et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease. Mol Neurodegener. 2021;16:6. Available from: https:\/\/doi.org\/10.1186\/s13024-021-00427-6.","DOI":"10.1186\/s13024-021-00427-6"},{"key":"766_CR26","doi-asserted-by":"publisher","unstructured":"Espinosa-Oliva AM, Ruiz R, Soto MS, Boza-Serrano A, Rodriguez-Perez AI, Roca-Ceballos MA, et al. Inflammatory bowel disease induces pathological \u03b1-synuclein aggregation in the human gut and brain. Neuropathol Appl Neurobiol. 2024;50:e12962. Available from: https:\/\/doi.org\/10.1111\/nan.12962.","DOI":"10.1111\/nan.12962"},{"key":"766_CR27","doi-asserted-by":"crossref","unstructured":"Gray MT, Woulfe JM. Striatal blood-brain barrier permeability in Parkinson\u2019s disease. J Cereb Blood Flow Metab. 2015\/03\/11. 2015;35:747\u201350. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25757748.","DOI":"10.1038\/jcbfm.2015.32"},{"key":"766_CR28","doi-asserted-by":"crossref","unstructured":"Sweeney MD, Sagare AP, Zlokovic B V. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018\/01\/29. 2018;14:133\u201350. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29377008.","DOI":"10.1038\/nrneurol.2017.188"},{"key":"766_CR29","doi-asserted-by":"publisher","unstructured":"Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, et al. Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Movement Disorders. 2017;32:739\u201349. Available from: https:\/\/doi.org\/10.1002\/mds.26942.","DOI":"10.1002\/mds.26942"},{"key":"766_CR30","doi-asserted-by":"crossref","unstructured":"Scheperjans F, Derkinderen P, Borghammer P. The Gut and Parkinson\u2019s Disease: Hype or Hope? J Parkinsons Dis. 2018;8:S31\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30584161.","DOI":"10.3233\/JPD-181477"},{"key":"766_CR31","doi-asserted-by":"publisher","unstructured":"Matarrese P, Falzano L, Fabbri A, Gambardella L, Frank C, Geny B, et al. Clostridium difficile Toxin B Causes Apoptosis in Epithelial Cells by Thrilling Mitochondria. Involvement of ATP-sensitive Mitochondrial Potassium Channels. Journal of Biological Chemistry. 2007;282:9029\u201341. Available from: https:\/\/doi.org\/10.1074\/jbc.M607614200.","DOI":"10.1074\/jbc.M607614200"},{"key":"766_CR32","doi-asserted-by":"crossref","unstructured":"Suzuki M, Danilchanka O, Mekalanos JJ. Vibrio cholerae T3SS Effector VopE Modulates Mitochondrial Dynamics and Innate Immune Signaling by Targeting Miro GTPases. Cell Host Microbe. 2014;16:581\u201391. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1931312814003485.","DOI":"10.1016\/j.chom.2014.09.015"},{"key":"766_CR33","doi-asserted-by":"crossref","unstructured":"Cardoso SM. The Mitochondrial Cascade Hypothesis for Parkinsons Disease. Curr Pharm Des. 2011. p. 3390\u20137. Available from: http:\/\/www.eurekaselect.com\/node\/75523\/article.","DOI":"10.2174\/138161211798072508"},{"key":"766_CR34","doi-asserted-by":"crossref","unstructured":"Cardoso SM, Empadinhas N. The Microbiome-Mitochondria Dance in Prodromal Parkinson\u2019s Disease. Front Physiol. 2018;9:471. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2018.00471.","DOI":"10.3389\/fphys.2018.00471"},{"key":"766_CR35","doi-asserted-by":"publisher","unstructured":"Yu J, Meng J, Qin Z, Yu Y, Liang Y, Wang Y, et al. Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson\u2019s disease. J Neuroinflammation. 2023;20:117. Available from: \nhttps:\/\/doi.org\/10.1186\/s12974-023-02782-1.","DOI":"10.1186\/s12974-023-02782-1"},{"key":"766_CR36","doi-asserted-by":"publisher","unstructured":"Boehme M, Guzzetta KE, Bastiaanssen TFS, van de Wouw M, Moloney GM, Gual-Grau A, et al. Microbiota from young mice counteracts selective age-associated behavioral deficits. Nat Aging. 2021;1:666\u201376. Available from: https:\/\/doi.org\/10.1038\/s43587-021-00093-9.","DOI":"10.1038\/s43587-021-00093-9"},{"key":"766_CR37","doi-asserted-by":"publisher","unstructured":"Parker A, Romano S, Ansorge R, Aboelnour A, Le Gall G, Savva GM, et al. Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain. Microbiome. 2022;10:68. Available from: https:\/\/doi.org\/10.1186\/s40168-022-01243-w.","DOI":"10.1186\/s40168-022-01243-w"},{"key":"766_CR38","doi-asserted-by":"crossref","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinsons disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181\u20134. Available from: https:\/\/jnnp.bmj.com\/content\/55\/3\/181.","DOI":"10.1136\/jnnp.55.3.181"},{"key":"766_CR39","doi-asserted-by":"publisher","unstructured":"Tiago I, Ver\u00edssimo A. Microbial and functional diversity of a subterrestrial high pH groundwater associated to serpentinization. Environ Microbiol. 2013;15:1687\u2013706. Available from: https:\/\/doi.org\/10.1111\/1462-2920.12034.","DOI":"10.1111\/1462-2920.12034"},{"key":"766_CR40","doi-asserted-by":"publisher","unstructured":"Parada AE, Needham DM, Fuhrman JA. Every base matters: assessing small subunit rRNA primers for marine microbiomes with mock communities, time series and global field samples. Environ Microbiol. 2016;18:1403\u201314. Available from: https:\/\/doi.org\/10.1111\/1462-2920.13023.","DOI":"10.1111\/1462-2920.13023"},{"key":"766_CR41","doi-asserted-by":"crossref","unstructured":"Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities. Appl Environ Microbiol. 2009;75:7537 LP \u2013 7541. Available from: http:\/\/aem.asm.org\/content\/75\/23\/7537.abstract.","DOI":"10.1128\/AEM.01541-09"},{"key":"766_CR42","doi-asserted-by":"crossref","unstructured":"Gl\u00f6ckner FO, Yilmaz P, Quast C, Gerken J, Beccati A, Ciuprina A, et al. 25 years of serving the community with ribosomal RNA gene reference databases and tools. J Biotechnol. 2017;261:169\u201376. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168165617314943.","DOI":"10.1016\/j.jbiotec.2017.06.1198"},{"key":"766_CR43","doi-asserted-by":"publisher","unstructured":"Munoz Pinto MF, Campbell SJ, Simoglou Karali C, Johanssen VA, Bristow C, Cheng VWT, et al. Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein. Neuro Oncol. 2022;24:52\u201363. Available from: https:\/\/doi.org\/10.1093\/neuonc\/noab177.","DOI":"10.1093\/neuonc\/noab177"},{"key":"766_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3233\/JPD-160991","volume":"7","author":"PA Engen","year":"2017","unstructured":"Engen PA, Dodiya HB, Naqib A, Forsyth CB, Green SJ, Voigt RM, et al. The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy. J Parkinsons Dis. 2017;7:331\u201346.","journal-title":"J Parkinsons Dis"},{"key":"766_CR45","doi-asserted-by":"crossref","unstructured":"Perez-Pardo P, Dodiya HB, Engen PA, Forsyth CB, Huschens AM, Shaikh M, et al. Role of TLR4 in the gut-brain axis in Parkinson\u2019s disease: a translational study from men to mice. Gut. 2019;68:829 LP \u2013 843. Available from: http:\/\/gut.bmj.com\/content\/68\/5\/829.abstract.","DOI":"10.1136\/gutjnl-2018-316844"},{"key":"766_CR46","doi-asserted-by":"crossref","unstructured":"Valente AJ, Maddalena LA, Robb EL, Moradi F, Stuart JA. A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture. Acta Histochem. 2017;119:315\u201326. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0065128116303658.","DOI":"10.1016\/j.acthis.2017.03.001"},{"key":"766_CR47","doi-asserted-by":"publisher","unstructured":"Gundersen HJ, Jensen EB V, Kieu K, Nielsen J. The efficiency of systematic sampling in stereology \u2014 reconsidered. J Microsc. 1999;193:199\u2013211. Available from: https:\/\/doi.org\/10.1046\/j.1365-2818.1999.00457.x.","DOI":"10.1046\/j.1365-2818.1999.00457.x"},{"key":"766_CR48","doi-asserted-by":"publisher","unstructured":"Ferreira IL, Carmo C, Naia L, I. Mota S, Cristina Rego A. Assessing Mitochondrial Function in In Vitro and Ex Vivo Models of Huntington\u2019s Disease BT - Huntington\u2019s Disease. In: Precious S V, Rosser AE, Dunnett SB, editors. New York, NY: Springer New York; 2018. p. 415\u201342. Available from: https:\/\/doi.org\/10.1007\/978-1-4939-7825-0_19.","DOI":"10.1007\/978-1-4939-7825-0_19"},{"key":"766_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021746","volume":"6","author":"GW Rogers","year":"2011","unstructured":"Rogers GW, Brand MD, Petrosyan S, Ashok D, Elorza AA, Ferrick DA, et al. High Throughput Microplate Respiratory Measurements Using Minimal Quantities Of Isolated Mitochondria. PLoS ONE. 2011;6: e21746.","journal-title":"PLoS ONE"},{"key":"766_CR50","doi-asserted-by":"crossref","unstructured":"Dodiya HB, Forsyth CB, Voigt RM, Engen PA, Patel J, Shaikh M, et al. Chronic stress-induced gut dysfunction exacerbates Parkinson\u2019s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson\u2019s disease. Neurobiol Dis. 2020;135:104352. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S096999611830768X.","DOI":"10.1016\/j.nbd.2018.12.012"},{"key":"766_CR51","doi-asserted-by":"crossref","unstructured":"Minato T, Maeda T, Fujisawa Y, Tsuji H, Nomoto K, Ohno K, et al. Progression of Parkinson\u2019s disease is associated with gut dysbiosis: Two-year follow-up study. PLoS One. 2017;12:e0187307\u2013e0187307. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29091972.","DOI":"10.1371\/journal.pone.0187307"},{"key":"766_CR52","doi-asserted-by":"publisher","unstructured":"Metta V, Leta V, Mrudula KR, Prashanth LK, Goyal V, Borgohain R, et al. Gastrointestinal dysfunction in Parkinson\u2019s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation. J Neurol. 2022;269:1154\u201363. Available from: https:\/\/doi.org\/10.1007\/s00415-021-10567-w.","DOI":"10.1007\/s00415-021-10567-w"},{"key":"766_CR53","doi-asserted-by":"publisher","unstructured":"Cheng Y, Tan G, Zhu Q, Wang C, Ruan G, Ying S, et al. Efficacy of fecal microbiota transplantation in patients with Parkinson\u2019s disease: clinical trial results from a randomized, placebo-controlled design. Gut Microbes. 2023;15:2284247. Available from: https:\/\/doi.org\/10.1080\/19490976.2023.2284247.","DOI":"10.1080\/19490976.2023.2284247"},{"key":"766_CR54","doi-asserted-by":"crossref","unstructured":"DuPont HL, Suescun J, Jiang Z-D, Brown EL, Essigmann HT, Alexander AS, et al. Fecal microbiota transplantation in Parkinson\u2019s disease\u2014A randomized repeat-dose, placebo-controlled clinical pilot study. Front Neurol. 2023;14. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1104759.","DOI":"10.3389\/fneur.2023.1104759"},{"key":"766_CR55","doi-asserted-by":"publisher","first-page":"S371","DOI":"10.3233\/JPD-191802","volume":"9","author":"T Van Laar","year":"2019","unstructured":"Van Laar T, Boertien JM, Herranz AH. Faecal Transplantation, Pro- and Prebiotics in Parkinson\u2019s Disease; Hope or Hype? J Parkinsons Dis. 2019;9:S371\u20139.","journal-title":"J Parkinsons Dis"},{"key":"766_CR56","doi-asserted-by":"crossref","unstructured":"Cheng H-C, Ulane CM, Burke RE. Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol. 2010;67:715\u201325. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20517933.","DOI":"10.1002\/ana.21995"},{"key":"766_CR57","doi-asserted-by":"crossref","unstructured":"Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 2015\/10\/26. 2016;14:20\u201332. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26499895.","DOI":"10.1038\/nrmicro3552"},{"key":"766_CR58","doi-asserted-by":"crossref","unstructured":"Bedoya SK, Wilson TD, Collins EL, Lau K, III JL. Isolation and Th17 Differentiation of Naive CD4 T Lymphocytes. JoVE. 2013;e50765. Available from: https:\/\/app.jove.com\/50765.","DOI":"10.3791\/50765"},{"key":"766_CR59","doi-asserted-by":"publisher","unstructured":"Flannigan KL, Denning TL. Segmented filamentous bacteria-induced immune responses: a balancing act between host protection and autoimmunity. Immunology. 2018;154:537\u201346. Available from: https:\/\/doi.org\/10.1111\/imm.12950.","DOI":"10.1111\/imm.12950"},{"key":"766_CR60","doi-asserted-by":"publisher","unstructured":"Jonsson H, Hugerth LW, Sundh J, Lundin E, Andersson AF. Genome sequence of segmented filamentous bacteria present in the human intestine. Commun Biol. 2020;3:485. Available from: https:\/\/doi.org\/10.1038\/s42003-020-01214-7.","DOI":"10.1038\/s42003-020-01214-7"},{"key":"766_CR61","doi-asserted-by":"crossref","unstructured":"Tan TG, Sefik E, Geva-Zatorsky N, Kua L, Naskar D, Teng F, et al. Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proceedings of the National Academy of Sciences. 2016;113:E8141 LP-E8150. Available from: http:\/\/www.pnas.org\/content\/113\/50\/E8141.abstract.","DOI":"10.1073\/pnas.1617460113"},{"key":"766_CR62","doi-asserted-by":"publisher","unstructured":"Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cellular and Molecular Life Sciences. 2013;70:631\u201359. Available from: https:\/\/doi.org\/10.1007\/s00018-012-1070-x.","DOI":"10.1007\/s00018-012-1070-x"},{"key":"766_CR63","doi-asserted-by":"publisher","unstructured":"Bhoite SS, Han Y, Ruotolo BT, Chapman MR. Mechanistic insights into accelerated &#x3b1;-synuclein aggregation mediated by human microbiome-associated functional amyloids. Journal of Biological Chemistry. 2022;298. Available from: https:\/\/doi.org\/10.1016\/j.jbc.2022.102088.","DOI":"10.1016\/j.jbc.2022.102088"},{"key":"766_CR64","doi-asserted-by":"crossref","unstructured":"Esteves AR, Silva DF, Banha D, Candeias E, Guedes B, Cardoso SM. LPS-induced mitochondrial dysfunction regulates innate immunity activation and \u03b1-synuclein oligomerization in Parkinson\u2019s disease. Redox Biol. 2023;63:102714. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2213231723001155.","DOI":"10.1016\/j.redox.2023.102714"},{"key":"766_CR65","doi-asserted-by":"crossref","unstructured":"Magalh\u00e3es JD, Esteves AR, Candeias E, Silva DF, Empadinhas N, Cardoso SM. The Role of Bacteria-Mitochondria Communication in the Activation of Neuronal Innate Immunity: Implications to Parkinson\u00b4s Disease. Int J Mol Sci. 2023;24. Available from: https:\/\/www.mdpi.com\/1422-0067\/24\/5\/4339.","DOI":"10.3390\/ijms24054339"},{"key":"766_CR66","doi-asserted-by":"crossref","unstructured":"Villase\u00f1or R, Kuennecke B, Ozmen L, Ammann M, Kugler C, Gr\u00fcninger F, et al. Region-specific permeability of the blood-brain barrier upon pericyte loss. J Cereb Blood Flow Metab. 2017\/03\/01. 2017;37:3683\u201394. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28273726.","DOI":"10.1177\/0271678X17697340"},{"key":"766_CR67","doi-asserted-by":"crossref","unstructured":"Woerman AL, Tamg\u00fcney G. Body-first Parkinson\u2019s disease and variant Creutzfeldt-Jakob disease - similar or different? Neurobiol Dis. 2022;164:105625. Available from: http:\/\/europepmc.org\/abstract\/MED\/35026401.","DOI":"10.1016\/j.nbd.2022.105625"},{"key":"766_CR68","doi-asserted-by":"crossref","unstructured":"Yang M, Zhao X, Miselis RR. The origin of catecholaminergic nerve fibers in the subdiaphragmatic vagus nerve of rat. J Auton Nerv Syst. 1999;76:108\u201317. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0165183899000144.","DOI":"10.1016\/S0165-1838(99)00014-4"},{"key":"766_CR69","doi-asserted-by":"publisher","unstructured":"Bader V, Winklhofer KF. PINK1 and Parkin: team players in stress-induced mitophagy. Biol Chem. 2020;401:891\u20139. Available from: https:\/\/doi.org\/10.1515\/hsz-2020-0135.","DOI":"10.1515\/hsz-2020-0135"},{"key":"766_CR70","doi-asserted-by":"crossref","unstructured":"Silva DF, Candeias E, Esteves AR, Magalh\u00e3es JD, Ferreira IL, Nunes-Costa D, et al. Microbial BMAA elicits mitochondrial dysfunction, innate immunity activation, and Alzheimer\u2019s disease features in cortical neurons. J Neuroinflammation. 2020;17:332. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33153477.","DOI":"10.1186\/s12974-020-02004-y"},{"key":"766_CR71","doi-asserted-by":"crossref","unstructured":"Zhou K, Shi L, Wang Y, Chen S, Zhang J. Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders. J Immunol Res. 2016\/08\/29. 2016;2016:9238290. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27652274.","DOI":"10.1155\/2016\/9238290"},{"key":"766_CR72","doi-asserted-by":"crossref","unstructured":"Storelli E, Cassina N, Rasini E, Marino F, Cosentino M. Do Th17 Lymphocytes and IL-17 Contribute to Parkinson\u2019s Disease? A Systematic Review of Available Evidence. Front Neurol. 2019;10:13. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00013.","DOI":"10.3389\/fneur.2019.00013"},{"key":"766_CR73","doi-asserted-by":"crossref","unstructured":"Pereira-Santos AR, Candeias E, Magalh\u00e3es JD, Empadinhas N, Esteves AR, Cardoso SM. Neuronal control of microglia through the mitochondria. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2024;1870:167167. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S092544392400156X.","DOI":"10.1016\/j.bbadis.2024.167167"},{"key":"766_CR74","doi-asserted-by":"publisher","unstructured":"Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P. Triggers , Facilitators , and Aggravators\u202f: Rede fi ning Parkinson \u2019 s Disease Pathogenesis. Trends Neurosci. 2019;42:4\u201313. Available from: https:\/\/doi.org\/10.1016\/j.tins.2018.09.007.","DOI":"10.1016\/j.tins.2018.09.007"},{"key":"766_CR75","doi-asserted-by":"crossref","unstructured":"Haran JP, McCormick BA. Aging, Frailty, and the Microbiome\u2014How Dysbiosis Influences Human Aging and Disease. Gastroenterology. 2021;160:507\u201323. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0016508520355347.","DOI":"10.1053\/j.gastro.2020.09.060"},{"key":"766_CR76","doi-asserted-by":"crossref","unstructured":"Munoz-Pinto MF, Empadinhas N, Cardoso SM. The neuromicrobiology of Parkinson\u2019s disease: A unifying theory. Ageing Res Rev. 2021;70:101396. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1568163721001434.","DOI":"10.1016\/j.arr.2021.101396"},{"key":"766_CR77","doi-asserted-by":"crossref","unstructured":"Borghammer P, Horsager J, Andersen K, Van Den Berge N, Raunio A, Murayama S, et al. Neuropathological evidence of body-first vs. brain-first Lewy body disease. Neurobiol Dis. 2021;161:105557. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0969996121003065.","DOI":"10.1016\/j.nbd.2021.105557"},{"key":"766_CR78","doi-asserted-by":"publisher","unstructured":"Borghammer P. The brain-first vs. body-first model of Parkinson\u2019s disease with comparison to alternative models. J Neural Transm. 2023;130:737\u201353. Available from: https:\/\/doi.org\/10.1007\/s00702-023-02633-6.","DOI":"10.1007\/s00702-023-02633-6"},{"key":"766_CR79","doi-asserted-by":"crossref","unstructured":"Villageli\u00fa DN, Borts DJ, Lyte M. Production of the Neurotoxin Salsolinol by a Gut-Associated Bacterium and Its Modulation by Alcohol. Front Microbiol. 2018;9. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2018.03092.","DOI":"10.3389\/fmicb.2018.03092"},{"key":"766_CR80","doi-asserted-by":"crossref","unstructured":"Nunes-Costa D, Magalh\u00e3es JD, G-Fernandes M, Cardoso SM, Empadinhas N. Microbial BMAA and the Pathway for Parkinson\u2019s Disease Neurodegeneration. Front Aging Neurosci. 2020;12:26. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2020.00026.","DOI":"10.3389\/fnagi.2020.00026"},{"key":"766_CR81","doi-asserted-by":"crossref","unstructured":"Sampson T. The impact of indigenous microbes on Parkinson\u2019s disease. Neurobiol Dis. 2020;135:104426. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0969996119300695.","DOI":"10.1016\/j.nbd.2019.03.014"},{"key":"766_CR82","doi-asserted-by":"publisher","unstructured":"Huang B, Chau SWH, Liu Y, Chan JWY, Wang J, Ma SL, et al. Gut microbiome dysbiosis across early Parkinson\u2019s disease, REM sleep behavior disorder and their first-degree relatives. Nat Commun. 2023;14:2501. Available from: https:\/\/doi.org\/10.1038\/s41467-023-38248-4.","DOI":"10.1038\/s41467-023-38248-4"},{"key":"766_CR83","doi-asserted-by":"crossref","unstructured":"Li T, Chu C, Yu L, Zhai Q, Wang S, Zhao J, et al. Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson&rsquo;s Disease. Nutrients. 2022;14. Available from: https:\/\/www.mdpi.com\/2072-6643\/14\/21\/4678.","DOI":"10.3390\/nu14214678"},{"key":"766_CR84","doi-asserted-by":"publisher","unstructured":"Nishiwaki H, Ito M, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y, et al. Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson\u2019s disease. NPJ Parkinsons Dis. 2022;8:65. Available from: https:\/\/doi.org\/10.1038\/s41531-022-00328-5.","DOI":"10.1038\/s41531-022-00328-5"},{"key":"766_CR85","doi-asserted-by":"crossref","unstructured":"Hedblom GA, Reiland HA, Sylte MJ, Johnson TJ, Baumler DJ. Segmented Filamentous Bacteria \u2013 Metabolism Meets Immunity. Front Microbiol. 2018;9. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2018.01991.","DOI":"10.3389\/fmicb.2018.01991"},{"key":"766_CR86","doi-asserted-by":"publisher","unstructured":"Hall JA, Pokrovskii M, Kroehling L, Kim B-R, Kim SY, Wu L, et al. Transcription factor ROR&#x3b1; enforces stability of the Th17 cell effector program by binding to a <em>Rorc cis<\/em>-regulatory element. Immunity. 2022;55:2027\u20132043.e9. Available from: https:\/\/doi.org\/10.1016\/j.immuni.2022.09.013.","DOI":"10.1016\/j.immuni.2022.09.013"},{"key":"766_CR87","doi-asserted-by":"publisher","unstructured":"Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria. Cell. 2009;139:485\u201398. Available from: https:\/\/doi.org\/10.1016\/j.cell.2009.09.033.","DOI":"10.1016\/j.cell.2009.09.033"},{"key":"766_CR88","doi-asserted-by":"publisher","unstructured":"Fu J, Huang Y, Bao T, Liu C, Liu X, Chen X. The role of Th17 cells\/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A. J Neuroinflammation. 2022;19:98. Available from: https:\/\/doi.org\/10.1186\/s12974-022-02446-6.","DOI":"10.1186\/s12974-022-02446-6"},{"key":"766_CR89","doi-asserted-by":"publisher","unstructured":"Sommer A, Marxreiter F, Krach F, Fadler T, Grosch J, Maroni M, et al. Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson&#x2019;s Disease. Cell Stem Cell. 2018;23:123\u2013131.e6. Available from: https:\/\/doi.org\/10.1016\/j.stem.2018.06.015.","DOI":"10.1016\/j.stem.2018.06.015"},{"key":"766_CR90","doi-asserted-by":"publisher","unstructured":"Diener C, Hart M, Kehl T, Becker-Dorison A, T\u00e4nzer T, Schub D, et al. Time-resolved RNA signatures of CD4+ T cells in Parkinson\u2019s disease. Cell Death Discov. 2023;9:18. Available from: https:\/\/doi.org\/10.1038\/s41420-023-01333-0.","DOI":"10.1038\/s41420-023-01333-0"},{"key":"766_CR91","doi-asserted-by":"publisher","unstructured":"Mills KHG. IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol. 2023;23:38\u201354. Available from: https:\/\/doi.org\/10.1038\/s41577-022-00746-9.","DOI":"10.1038\/s41577-022-00746-9"},{"key":"766_CR92","doi-asserted-by":"crossref","unstructured":"Jackson A, Engen PA, Forsyth CB, Shaikh M, Naqib A, Wilber S, et al. Intestinal Barrier Dysfunction in the Absence of Systemic Inflammation Fails to Exacerbate Motor Dysfunction and Brain Pathology in a Mouse Model of Parkinson\u2019s Disease. Front Neurol. 2022;13. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.882628.","DOI":"10.3389\/fneur.2022.882628"},{"key":"766_CR93","doi-asserted-by":"publisher","unstructured":"Burke RE, Dauer WT, Vonsattel JPG. A critical evaluation of the Braak staging scheme for Parkinson\u2019s disease. Ann Neurol. 2008;64:485\u201391. Available from: https:\/\/doi.org\/10.1002\/ana.21541.","DOI":"10.1002\/ana.21541"},{"key":"766_CR94","doi-asserted-by":"publisher","unstructured":"Walsh DM, Selkoe DJ. A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. Nat Rev Neurosci. 2016;17:251\u201360. Available from: https:\/\/doi.org\/10.1038\/nrn.2016.13.","DOI":"10.1038\/nrn.2016.13"},{"key":"766_CR95","doi-asserted-by":"publisher","unstructured":"Antunes L, Frasquilho S, Ostaszewski M, Weber Jos, Longhino L, Antony P, et al. Similar \u03b1-Synuclein staining in the colon mucosa in patients with Parkinson\u2019s disease and controls. Movement Disorders. 2016;31:1567\u201370. Available from: https:\/\/doi.org\/10.1002\/mds.26702.","DOI":"10.1002\/mds.26702"},{"key":"766_CR96","doi-asserted-by":"publisher","unstructured":"Gray MT, Munoz DG, Gray DA, Schlossmacher MG, Woulfe JM. Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects. Movement Disorders. 2014;29:991\u20138. Available from: https:\/\/doi.org\/10.1002\/mds.25779.","DOI":"10.1002\/mds.25779"},{"key":"766_CR97","doi-asserted-by":"crossref","unstructured":"Visanji NP, Marras C, Kern DS, Al Dakheel A, Gao A, Liu LWC, et al. Colonic mucosal \u03b1-synuclein lacks specificity as a biomarker for Parkinson disease. Neurology. 2015;84:609 LP \u2013 616. Available from: http:\/\/n.neurology.org\/content\/84\/6\/609.abstract.","DOI":"10.1212\/WNL.0000000000001240"},{"key":"766_CR98","doi-asserted-by":"publisher","unstructured":"Mu\u00f1oz-Delgado L, Mac\u00edas-Garc\u00eda D, Peri\u00f1\u00e1n MT, Jes\u00fas S, Adarmes-G\u00f3mez AD, Bonilla Toribio M, et al. Peripheral inflammatory immune response differs among sporadic and familial Parkinson\u2019s disease. NPJ Parkinsons Dis. 2023;9:12. Available from: https:\/\/doi.org\/10.1038\/s41531-023-00457-5.","DOI":"10.1038\/s41531-023-00457-5"},{"key":"766_CR99","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.4049\/jimmunol.1103460","volume":"189","author":"MA Lopez-Ramirez","year":"2016","unstructured":"Lopez-Ramirez MA, Fischer R, Claudia C, Davies HA, Logan K, Male DK, et al. Role of Caspases in Cytokine-Induced Barrier Breakdown in Human Brain Endothelial Cells. J Immunol. 2016;189:3130\u20139.","journal-title":"J Immunol"},{"key":"766_CR100","doi-asserted-by":"publisher","unstructured":"D. Magalh\u00e3es J, Candeias E, Melo-Marques I, Silva DF, Esteves AR, Empadinhas N, et al. Intestinal infection triggers mitochondria-mediated \u03b1-synuclein pathology: relevance to Parkinson\u2019s disease. Cellular and Molecular Life Sciences. 2023;80:166. Available from: https:\/\/doi.org\/10.1007\/s00018-023-04819-3.","DOI":"10.1007\/s00018-023-04819-3"},{"key":"766_CR101","doi-asserted-by":"publisher","unstructured":"Choi ML, Chappard A, Singh BP, Maclachlan C, Rodrigues M, Fedotova EI, et al. Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity. Nat Neurosci. 2022;25:1134\u201348. Available from: https:\/\/doi.org\/10.1038\/s41593-022-01140-3.","DOI":"10.1038\/s41593-022-01140-3"},{"key":"766_CR102","doi-asserted-by":"publisher","unstructured":"Matheoud D, Cannon T, Voisin A, Penttinen A-M, Ramet L, Fahmy AM, et al. Intestinal infection triggers Parkinson\u2019s disease-like symptoms in Pink1\u2212\/\u2212 mice. Nature. 2019;571:565\u20139. Available from: https:\/\/doi.org\/10.1038\/s41586-019-1405-y.","DOI":"10.1038\/s41586-019-1405-y"},{"key":"766_CR103","doi-asserted-by":"crossref","unstructured":"Matheoud D, Sugiura A, Gagnon E, Mcbride HM, Laplante A, Rondeau C, et al. Parkinson\u2019s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation. Cell. 2016;166:314\u201327.","DOI":"10.1016\/j.cell.2016.05.039"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-024-00766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-024-00766-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-024-00766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T15:05:48Z","timestamp":1729782348000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-024-00766-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1186\/s13024-024-00766-0","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Faculty of Medicine of the University of Coimbra (FMUC) Ethics Committee and the University Hospital of Coimbra (CHUC) Ethics Committee approved the informed consent forms and the collection and use of PD patients\u2019 fecal material, the collection and use of terminal ileum biopsies and medical clinical information. All samples were anonymized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}